Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -2.58M | -2.40M | -2.36M | -2.49M | -6.66M |
| Total Depreciation and Amortization | 94.70K | 99.60K | 105.60K | 109.10K | 109.50K |
| Total Amortization of Deferred Charges | 112.90K | 62.20K | 12.10K | -- | 133.40K |
| Total Other Non-Cash Items | 251.10K | 260.70K | 344.80K | 237.30K | 4.23M |
| Change in Net Operating Assets | 305.90K | 123.30K | -170.60K | -154.10K | -356.10K |
| Cash from Operations | -1.82M | -1.86M | -2.07M | -2.30M | -2.54M |
| Capital Expenditure | -10.70K | 0.00 | 18.00K | -2.70K | -5.50K |
| Sale of Property, Plant, and Equipment | 6.00K | 6.00K | 6.00K | 6.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.00K | -69.00K | -62.70K | -62.70K | -62.70K |
| Cash from Investing | -31.70K | -63.00K | -38.70K | -59.40K | -68.20K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -100.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 2.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | 2.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.85M | -1.92M | -2.11M | -2.36M | 40.00K |